The five producers behind the leading vaccine candidates now in phase 3 trials have signed contracts to supply more than half of all vaccine doses to be produced in the near future to a handful of developed nations and territories, including the US, UK, EU, Australia, Hong Kong and Macau, Japan, Switzerland, and Israel, Oxfam said, citing data collected by analytics company Airfinity.
Phase 3 is the final stage before approval, in which a vaccine and a placebo are tested on thousands of participants to verify the medicine is safe and effective.
Moderna revealed that the Phase-3 study of its Covid vaccine candidate, mRNA-1273, involving 30,000 volunteers in the United States, has enrolled 25,296 participants as of September 16.
The vaccine race has become deeply politicized in the United States in the run-up to the presidential election in November. The CDC laid out a distribution scenario for the last quarter of the year when a limited supply of one or two vaccines might be ready to be given to priority groups. The Trump administration has released a detailed road map on Wednesday of their plan to speed doses of coronavirus vaccine into millions of Americans.
However, the European Union has publicly said it wants to boost the production capacity of vaccine makers and share any excess doses with poorer nations. I trust vaccines. I trust the scientists, but I don't trust Donald Trump.
Moderna's CEO Stephane Bancel said on Thursday his company would know whether their vaccine works by November. It is "technically possible" for Moderna to get results in October, but this is unlikely, he said.
Early reviews of JK Rowling’s new book claim it includes transphobic elements
Rowling is releasing a crime thriller about a male serial killer who disguises as a woman, raising concerns on Twitter . The plot of " Troubled Blood ", the latest book by British writer J.K.
Experts and even officials from his own administration say the outcome of ongoing trials can not be predicted, and that they are unlikely to yield actionable results before the end of the year or early 2021.
The WHO chief also noted that the COVID-19 pandemic had proven that the world was woefully under prepared.
In August, the Commission paid AstraZeneca €336 million to secure under these conditions 300 million doses of its vaccine under development with an option to buy other 100 million shots.
Mexico is one of the nations taking part in phase 3 trials of the Russian vaccine and will receive 2,000 doses for this goal.
The company continues to expect to make 500 million to 1 billion doses of the vaccine in 2021, Moderna said in a filing with the USA securities regulator.
And as per the hints being received from the authorities so far, healthcare and frontline workers, or "COVID warriors", who are the forefront of the country's battle with the virus and are most susceptible to it, will be the first ones to receive any vaccine that passes all regulatory norms. The US remains the exception for reasons that aren't yet known.